ZimVie Transitions into New Era Following ARCHIMED Acquisition
ZimVie Completes Acquisition by ARCHIMED
ZimVie Inc., known for its significant role in the dental implant market, has successfully completed its acquisition by ARCHIMED. This partnership is aimed at fostering growth and innovation within ZimVie, paving the way for an exciting future in the healthcare landscape.
Details of the Acquisition
ARCHIMED, a distinguished investment firm centered on healthcare industries, finalized the deal originally announced earlier this year. Under the terms of the transaction, shareholders of ZimVie are to receive $19.00 in cash per share of common stock. Following the completion of this acquisition, ZimVie’s common stock will no longer be listed on any stock exchanges, marking a significant transition for the company.
Statements from Leadership
André-Michel Ballester, Managing Partner at ARCHIMED, expressed excitement about this strategic partnership. He stated, "We are thrilled to partner with ZimVie to drive its growth as a leader in the dental implant industry. ZimVie's innovative products and trusted brand resonate with our aim to support premier healthcare companies." This sentiment underscores ARCHIMED's commitment to enhancing ZimVie's market position and capabilities.
Valuable Advisors
In how the acquisition unfolded, it is notable that Centerview Partners acted as the exclusive financial advisor to ZimVie, while Cravath, Swaine & Moore LLP provided legal advisory services. On the other side, UBS Investment Bank steered ARCHIMED with financial guidance, complemented by legal advice from Latham & Watkins LLP. Their collective expertise has been crucial in ensuring the smooth progression of this deal.
About ZimVie
ZimVie, headquartered in Palm Beach Gardens, Florida, stands out as a leader in dental implants and restorative procedures. The company is committed to delivering innovative solutions that enhance patients' quality of life. Its diverse product portfolio includes dental implants, biomaterials, and advanced digital workflows, all aimed at improving dental health outcomes and restoring smiles.
A Focus on Innovation
By putting innovation at the forefront, ZimVie strives to transform dental care practices. The company is dedicated to supporting dental professionals with reliable solutions that not only restore function but also provide aesthetic appeal in dental care.
About ARCHIMED
ARCHIMED is a prominent investment firm that emphasizes the healthcare sector globally. With its operational and financial expertise, ARCHIMED enables healthcare companies to enhance their offerings and reach broader markets. Its areas of focus encompass diverse segments including diagnostics, biotechnology, and medical technology.
Strategic Vision and Growth
ARCHIMED's approach is geared towards fostering innovation and expansion within its partner companies. This strategic focus positions ARCHIMED as a catalyst for change in the healthcare landscape, supporting businesses to navigate the evolving challenges in the market.
Media Contact Information
ARCHIMED
Stéphanie Du Ché • stephanie.duche@archimed.group
(+33) 6 16 36 11 08
ZimVie
Grace Flowers • Grace.Flowers@ZimVie.com
(561) 319-6130
Frequently Asked Questions
What was the primary reason for ARCHIMED's acquisition of ZimVie?
ARCHIMED aimed to leverage ZimVie's innovative portfolio to boost growth within the dental implant market.
What will happen to ZimVie's stock after the acquisition?
ZimVie's common stock will no longer trade on the NASDAQ following the completion of the acquisition.
Who were the advisors involved in the acquisition deal?
The acquisition process saw Centerview Partners and UBS Investment Bank as major financial advisors, while legal advice was provided by Cravath, Swaine & Moore LLP and Latham & Watkins LLP.
How is ZimVie positioned in the dental implant market?
ZimVie is positioned as a global leader, known for its commitment to high-quality dental products and solutions aimed at improving the patient experience.
What opportunities does this acquisition bring for ZimVie?
This acquisition is expected to facilitate greater innovation, operational support, and market expansion, enhancing ZimVie's ability to serve dental professionals effectively.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.